Healthcare Analyst Song, along with CEO Zocca, CFO Sullivan and CMO Ahmad participate in a conference call to discuss upcoming interim data analysis from ongoing Ph3 pivotal study in 1L melanoma and potential expansion into cancers beyond melanoma on April 24 at 10:30 am hosted by Jefferies.Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOBT:
- IO Biotech appoints Shamsaei as SVP, Commercial Development
- IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
- IO Biotech presents data on IO102-IO103 vaccine at AACR 24
- IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
- IO Biotech appoints Faical Miyara as CBO
